Skip to content
Medical Health Aged Care, Mental Health

Monash expert: New Nature Medicine study into the use of psychedelic substance, psilocybin, for the treatment of anorexia nervosa

Monash University 2 mins read

The results from a Phase 1 clinical trial led by the University of California published today in Nature Medicine has found a single dose of the psychedelic substance psilocybin, administered alongside psychological support, is a safe and acceptable treatment for patients with anorexia nervosa and may decrease eating-disorder behaviours in a subset of patients.

Professor Chris Langmead from the Monash Institute of Pharmaceutical Sciences is available for interviews on this topic. Please note, Professor Langmead is not a subject matter expert on anorexia nervosa, however he is an expert on the current evidence pertaining to psilocybin and the role it might play in treating a range of mental health conditions. 

Contact: M: +61 (0)417 959083 / E: 

  • How the findings from the Nature Medicine study could pave the way toward evaluating psilocybin therapy as a new avenue for treatment of anorexia nervosa, and other difficult-to-treat mental health conditions.

  • How the Therapeutic Goods Administration’s (TGA) recent decision to reclassify psilocybin for the treatment of depression in certain patients places Australia at the forefront of research in this field globally - and what needs to be done to seize the opportunity. 

The following quotes can be attributed to Professor Chris Langmead:

“Anorexia nervosa affects the lives of approximately one million Australians, yet there is currently a lack of safe and effective medical treatments for patients living with this condition. Mounting evidence has shown psilocybin therapy to be a promising treatment to help manage various mental health conditions for which current treatments are falling short.

“Despite the increased prevalence of difficult-to-treat mental health conditions throughout the community, very few advancements in new safe and effective treatments have emerged over the last 50 years - this simply isn’t good enough. My hope is that the TGA’s decision will pave the way for the development of new safe, effective and widely accessible medicines to significantly improve the lives of those living with mental health conditions.”


More from this category

  • Medical Health Aged Care
  • 29/11/2023
  • 12:07
Hola Health

Leading health tech firm named among fastest-growing Australian start-ups

Hola Health, a leading local health tech start-up providing telehealth and online script fulfillment services to a growing number of Australians, has been named in the top 5 fastest-growing new companies in the country in a prestigious annual list. The Australian Financial Review’s Fast Starters list recognises Australia’s 100 fastest-growing start-ups and young companies.It shows Hola Health grew revenue from around $100,000 in 2020/21 to $3.8 million last financial year. It is on track to exceed $10 million in revenue by the end of this financial year. In naming Hola Health at number five on the list, the AFR hailed…

  • Contains:
  • Medical Health Aged Care
  • 29/11/2023
  • 07:34
Public Health Association of Australia / Australian and New Zealand Journal of Public Health

New research reveals how babies and toddlers are targeted with unhealthy foods

Wednesday 29 November 2023 Babies and toddlers can't read or buy food yet, but new research reveals that they are being targeted with aggressive marketing in the baby and toddler aisle at the supermarket. The research, published today in theAustralian and New Zealand Journal of Public Health,has prompted health experts to call for regulation of on-pack labelling and promotional techniques used on baby and toddler food. Authors analysed 230 product packs found in two major supermarkets to uncover the marketing techniques used by manufacturers of products for children aged from just six months to three years. They found that 9…

  • Medical Health Aged Care
  • 29/11/2023
  • 06:05
Royal Australian College of GPs

RACGP backs duty of care bill for climate change harms

Australia’s largest representative body for GPs has thrown its support behind a duty of care bill requiring the Federal Government to protect young people from climate change harms in decision-making. It comes in the lead up to the first-ever Health Day at the COP28 UN Climate Conference, on Sunday 3 December, which will highlight the health impacts of climate change and the health case for climate action. Independent ACT Senator David Pocock introduced the bill which proposes government must consider the wellbeing of young people and future generations when making decisions that facilitate or fund projects that could significantly increase…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time your distribute with Medianet. Pay per release or save with a subscription.